Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Digambar Behera

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Future Oncology (London, England)|November 12, 2019
XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genesAmrita Singh, Navneet Singh, Digambar Behera, et al.
The International Journal of Biological Markers|July 12, 2016
Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokersYashila Girdhar, Navneet Singh, Digambar Behera, et al.
Pathology Oncology Research : POR|December 7, 2017
Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based ChemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
Molecular Biology Reports|February 5, 2018
Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 23, 2018
Genetic Variants in the Wingless Antagonist Genes (<i>sFRP</i>, <i>DKK</i>, and <i>Axin2</i>) Predict the Overall Survival and Prognosis of North Indian Lung Cancer Patients Treated with Platinum-Based Doublet ChemotherapyCharu Bahl, Navneet Singh, Digambar Behera, et al.
Medical Oncology (Northwood, London, England)|March 24, 2017
Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
BMJ Case Reports|January 25, 2013
Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsyKaran Madan, Navneet Singh, Ashim Das, et al.
Biochemical Genetics|March 9, 2018
Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North IndiansShweta Lawania, Navneet Singh, Digambar Behera, et al.
Future Oncology (London, England)|September 20, 2016
Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north IndiansCharu Bahl, Navneet Singh, Digambar Behera, et al.
Future Oncology (London, England)|December 8, 2018
XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian patients treated with platinum-based doublet chemotherapyShweta Lawania, Navneet Singh, Digambar Behera, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|November 12, 2019
XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genesAmrita Singh, Navneet Singh, Digambar Behera, et al.
The International Journal of Biological Markers|July 12, 2016
Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokersYashila Girdhar, Navneet Singh, Digambar Behera, et al.
Pathology Oncology Research : POR|December 7, 2017
Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based ChemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
Molecular Biology Reports|February 5, 2018
Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 23, 2018
Genetic Variants in the Wingless Antagonist Genes (<i>sFRP</i>, <i>DKK</i>, and <i>Axin2</i>) Predict the Overall Survival and Prognosis of North Indian Lung Cancer Patients Treated with Platinum-Based Doublet ChemotherapyCharu Bahl, Navneet Singh, Digambar Behera, et al.
Medical Oncology (Northwood, London, England)|March 24, 2017
Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapyAmrita Singh, Navneet Singh, Digambar Behera, et al.
BMJ Case Reports|January 25, 2013
Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsyKaran Madan, Navneet Singh, Ashim Das, et al.
Biochemical Genetics|March 9, 2018
Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North IndiansShweta Lawania, Navneet Singh, Digambar Behera, et al.
Future Oncology (London, England)|September 20, 2016
Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north IndiansCharu Bahl, Navneet Singh, Digambar Behera, et al.
Future Oncology (London, England)|December 8, 2018
XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian patients treated with platinum-based doublet chemotherapyShweta Lawania, Navneet Singh, Digambar Behera, et al.
Pageof 14